# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-19-004882
Filing Date
2019-02-27
Accepted
2019-02-27 16:02:21
Documents
64
Period of Report
2018-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | abio-10k_20181231.htm | 10-K | 2402653
2 | EX-23.1 | abio-ex231_8.htm | EX-23.1 | 3779
3 | EX-31.1 | abio-ex311_9.htm | EX-31.1 | 14996
4 | EX-31.2 | abio-ex312_6.htm | EX-31.2 | 16106
5 | EX-32.1 | abio-ex321_7.htm | EX-32.1 | 9350
6 | GRAPHIC | g120gpcy2axt000001.jpg | GRAPHIC | 8549
| Complete submission text file | 0001564590-19-004882.txt |  | 6703215

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL INSTANCE DOCUMENT | abio-20181231.xml | EX-101.INS | 1211994
8 | XBRL TAXONOMY EXTENSION SCHEMA | abio-20181231.xsd | EX-101.SCH | 43991
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | abio-20181231_cal.xml | EX-101.CAL | 40437
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | abio-20181231_def.xml | EX-101.DEF | 142258
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | abio-20181231_lab.xml | EX-101.LAB | 395843
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | abio-20181231_pre.xml | EX-101.PRE | 291038

Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22873 | Film No.: 19637605
SIC: 2835 In Vitro & In Vivo Diagnostic Substances